Indications and uses
temporarily protects and helps relieve chapped or cracked skin temporarily protects minor cuts scrapes burns
temporarily protects and helps relieve chapped or cracked skin temporarily protects minor cuts scrapes burns
Apply cream liberally as often as needed
Drug Facts
Dimethicone 1%
Skin protectant
For external use only
Apply cream liberally as often as needed
Water, Mineral Oil, White Petrolatum, Ceresin, Sorbitan Sesquioleate, Sorbitol, Lanolin Alcohol, Aluminum Hydroxide, Magnesium Hydroxide, BHT Ethylhexylglycerin, Phenoxyethanol
M-F 9a-5p CST
1-877-725-7274
Distributed by
pH R&D GinJen
Hammond, LA 70401
NDC 50952-009-11
SKIN PROTECTANT CREAM
Five Convenient 10ml Packets
GOOD
STUFF™
TO GO
Best darn tootin'
temp'rary protection
n' relief fer
all yer parts in
these parts fer minor
irr'tated, red,
cattle proddin', ,
cuts n' scrapes,
an' if
a cow
steps on
yer leg.
gitcha
some
Five 10ml (.35oz) Packets • Total Wt. 50g (grams)

| Class | Version | Type | Effective |
|---|---|---|---|
| DIMETHICONE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 50952-009-09 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e0e4-cd31-e053-dbdaa90ab51a | GoodStuff™ Skin Protectant Cream |
| 50952-009-10 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e0e4-cd31-e053-dbdaa90ab51a | GoodStuff™ Skin Protectant Cream |
| 50952-009-11 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e0e4-cd31-e053-dbdaa90ab51a | GoodStuff™ Skin Protectant Cream |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50952-009-09 | GoodStuff Skin Protectant | 10 g in 1 PACKET | CREAM | 10 | 1 | |
| 50952-009-10 | GoodStuff Skin Protectant | 57 g in 1 JAR | CREAM | 57 | 1 | |
| 50952-009-11 | GoodStuff Skin Protectant | 50 g in 1 PACKET | CREAM | 50 | 1 | |
| 50952-009-11 | GoodStuff Skin Protectant | 5 in 1 BOX | CREAM | 5 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Dimethicone | ACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Dimethicone | ACTIVE MOIETY | 92RU3N3Y1O | 1 | |
| Aluminum Hydroxide | INACTIVE INGREDIENT | 5QB0T2IUN0 | 1 | |
| Butylated Hydroxytoluene | INACTIVE INGREDIENT | 1P9D0Z171K | 1 | |
| Ceresin | INACTIVE INGREDIENT | Q1LS2UJO3A | 1 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| Lanolin Alcohols | INACTIVE INGREDIENT | 884C3FA9HE | 1 | |
| Magnesium Hydroxide | INACTIVE INGREDIENT | NBZ3QY004S | 1 | |
| Mineral Oil | INACTIVE INGREDIENT | T5L8T28FGP | 1 | |
| Petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Sorbitan Sesquioleate | INACTIVE INGREDIENT | 0W8RRI5W5A | 1 | |
| Sorbitol | INACTIVE INGREDIENT | 506T60A25R | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 50952-009 | 50952-009-09, 50952-009-10, 50952-009-11 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Dimethicone | 92RU3N3Y1O | ACTIB |
| Water | 059QF0KO0R | IACT |
| Mineral Oil | T5L8T28FGP | IACT |
| Petrolatum | 4T6H12BN9U | IACT |
| Ceresin | Q1LS2UJO3A | IACT |
| Sorbitan Sesquioleate | 0W8RRI5W5A | IACT |
| Sorbitol | 506T60A25R | IACT |
| Lanolin Alcohols | 884C3FA9HE | IACT |
| Aluminum Hydroxide | 5QB0T2IUN0 | IACT |
| Magnesium Hydroxide | NBZ3QY004S | IACT |
| Butylated Hydroxytoluene | 1P9D0Z171K | IACT |
| Ethylhexylglycerin | 147D247K3P | IACT |
| Phenoxyethanol | HIE492ZZ3T | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SHAMPOO / TOPICAL | 0.1 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TOPICAL | 654.36 mg | ||
| Ceresin | CERESIN | Q1LS2UJO3A | CREAM / VAGINAL | 280 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / INTRALESIONAL | 45 %w/v | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SYSTEM / TRANSDERMAL | 6.09 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | CREAM / TOPICAL | 36.8 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION / SUBCUTANEOUS | 4.7 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET / SUBLINGUAL | 50.5 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CREAM / TOPICAL | 2772 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE, EXTENDED RELEASE / ORAL | 120 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | EMULSION / TOPICAL | 7.8 %w/w | ||
| Lanolin Alcohols | LANOLIN ALCOHOLS | 884C3FA9HE | CREAM / TOPICAL | 6 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CAPSULE, EXTENDED RELEASE / ORAL | 0.03 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | LOTION / TOPICAL | 10.7 %w/w | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / TOPICAL | 6 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | SUPPOSITORY / VAGINAL | 27 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, DELAYED RELEASE / ORAL | 5.67 mg | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | TABLET, FILM COATED / ORAL | 43.4 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SOAP / TOPICAL | 0.82 %w/w | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | CREAM, AUGMENTED / TOPICAL | 26 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / RECTAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OINTMENT / TOPICAL | 9938 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, COATED / ORAL | 1.5 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | AEROSOL, FOAM / TOPICAL | 7.9 %w/w | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION / ORAL | 14 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 1.04 %w/v | ||
| Sorbitol | SORBITOL | 506T60A25R | INJECTION, SOLUTION / INTRAVENOUS | 4050 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET / SUBLINGUAL | 0.13 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | CAPSULE / ORAL | 120 mg | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | TABLET, CHEWABLE / ORAL | 750 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | TABLET, EXTENDED RELEASE / ORAL | 1 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SOLUTION, CONCENTRATE / ORAL | 0.1 mg/1ml | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | GEL / TOPICAL | 14 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | POWDER, FOR SUSPENSION / ORAL | 0.01 mg | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM, AUGMENTED / TOPICAL | 0.2 %w/w | ||
| Sorbitol | SORBITOL | 506T60A25R | LIQUID / TOPICAL | 1 %w/w | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | DROPS / ORAL | NA | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / TOPICAL | 7275 mg | ||
| Sorbitol | SORBITOL | 506T60A25R | SUSPENSION / RECTAL | 46.18 %w/v | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | INJECTION / INTRAVENOUS | NA | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | CREAM / VAGINAL | 0.05 %w/w | ||
| Magnesium Hydroxide | MAGNESIUM HYDROXIDE | NBZ3QY004S | TABLET, DELAYED RELEASE / ORAL | 150 mg | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | OIL / TOPICAL | 43.29 %v/v | ||
| Butylated Hydroxytoluene | BUTYLATED HYDROXYTOLUENE | 1P9D0Z171K | SUPPOSITORY / VAGINAL | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | LOTION / TOPICAL | 1428 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / AURICULAR (OTIC) | NA | ||
| Mineral Oil | MINERAL OIL | T5L8T28FGP | SUPPOSITORY / VAGINAL | 30 mg | ||
| Petrolatum | PETROLATUM | 4T6H12BN9U | OINTMENT / OPHTHALMIC | 88.4 %w/w |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ffb4a90f-636c-4f00-9c17-4d95eb522718 | 823ec0ea-55c9-451a-a2ce-0957f41a7549 | 2013-07-03 | Warnings | ffb4a90f-636c-4f00-9c17-4d95eb522718 823ec0ea-55c9-451a-a2ce-0957f41a7549 |
Adverse event summaries are temporarily unavailable. Other product information remains available.